Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'hg6 64 1'

Search results for: 'hg6 64 1'

Items 61-70 of 115

Page
per page
  1. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  2. SP2509
    B4894 SP2509
    Target: Histone Demethylases
    Summary: Demethylase 1 (LSD1) antagonist, novel Lysine-specific
      insoluble in H2O; insoluble in EtOH; ≥19.45 mg/mL
  3. XAV-939
    A1877 XAV-939
     1 Citation
    Target: TNKS
    Summary: Tankyrase 1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥15.62 mg/mL
  4. 1,2,3,4,5,6-Hexabromocyclohexane
    A4510 1,2,3,4,5,6-Hexabromocyclohexane
    Summary: JAK2 tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥8.22 mg/mL
  5. BMS-345541(free base)
    B4655 BMS-345541(free base)
    Summary: IKK-1/IKK-2 inhibitor,potent and selective
      insoluble in H2O; ≥70 mg/mL
  6. CYT387
    A4143 CYT387
     1 Citation
    Summary: JAK-1/-2 inhibitor,ATP competitive
      insoluble in EtOH; insoluble in H2O; ≥20.7 mg/mL
  7. Olaparib (AZD2281, Ku-0059436)
    A4154 Olaparib (AZD2281, Ku-0059436)
     12 Citation
    Summary: Potent PARP1/PARP2 inhibitor
      ≥21.72 mg/mL
  8. AMG-900
    A4119 AMG-900
    Summary: Aurora kinase inhibitor
      ≥25.2 mg/mL
  9. Chetomin
    A4505 Chetomin
    Summary: A4505 inhibitor
      soluble in DMSO
  10. Sanguinarine chloride
    B5970 Sanguinarine chloride
    Summary: Inhibitor of PP2C and MKP-1
      insoluble in H2O; insoluble in EtOH; ≥3.68 mg/mL

Items 61-70 of 115

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 8item
  2. Aurora Kinase 6item
  3. HDAC 15item
  4. Histone Acetyltransferases 3item
  5. Histone Demethylases 8item
  6. Histone Methyltransferase 9item
  7. HIF 6item
  8. JAK 17item
  9. PARP 17item
  10. Pim 7item
  11. Protein Ser/Thr Phosphatases 13item
  12. Sirtuin 5item
  13. Polycomb repressive complex 1 item
Specificity
  1. Selective 37item
Reversibility
  1. Reversible 1 item
  2. Irreversible 1 item
Target
  1. Histone Deacetylases (HDACs) 10item
  2. Aurora Kinases 5item
  3. MDM2 1 item
  4. EZH2 1 item
  5. Bromodomains 3item
  6. FLT3 2item
  7. RET 1 item
  8. MEK 1 item
  9. DOT1L 1 item
  10. Pim 2item
  11. Sir2-like Family Deacetylases (Sirtuins) 3item
  12. PP1 1 item
  13. PP2A 1 item
  14. Src 2item
  15. STAT 1 item
  16. Hypoxia Inducible Factors (HIFs) 1 item
  17. JAK 8item
  18. p300 1 item
  19. TNKS 1 item
  20. Topoisomerases 1 item
  21. DNA Methyltransferases 1 item
  22. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  23. PARP 5item
  24. phosphatases 1 item
  25. NAT10 1 item
  26. SETD7 1 item
  27. Histone Demethylases 1 item
  28. MNK 1 item
  29. Protein Arginine Methyltransferases 1 item
  30. PP4 1 item
  31. c-RET 1 item
  32. VEGFR3/FLT4 1 item
  33. NTRK1/TRKA 1 item
  34. CSF-1R/c-Fms 1 item
  35. Protein polybromo-1 1 item
  36. SMARCA4 1 item
  37. SMARCA2 1 item
  38. p53 2item
  39. Trx 1 item
  40. L3MBTL 1 item
  41. Lck 1 item
  42. p21 1 item
  43. 5-HT 1 item
Reported Experiments
  1. Animal Experiments 42item
  2. Cell Experiments 34item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Breast Cancer 5item
  3. Cancer 29item
  4. Cervical Cancer 1 item
  5. Colon Cancer 3item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Diabetes 1 item
  9. Epilepsy 1 item
  10. Glioma 1 item
  11. Hepatic Cancer 1 item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 2item
  15. Lung Cancer 1 item
  16. Lymphoma 2item
  17. Melanoma 1 item
  18. Mixed Lineage Leukemia 1 item
  19. Multiple Myeloma 2item
  20. Myelofibrosis 1 item
  21. Non-small Cell Lung Cancer 2item
  22. Ovarian Cancer 3item
  23. Pancreatic Cancer 2item
  24. Prostate Cancer 5item
  25. Renal Cell Carcinoma 1 item
  26. Rheumatoid Arthritis 1 item